Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer

Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017)

In: ((Bitte Journal prüfen)), 71.

Forschungsartikel (Zeitschrift)

Influence of statins on survival outcome in patients with metastatic castration resistant prostate cancer treated with abiraterone acetate

Boegemann M., Schlack K., Fischer A., Gerß J., Steinestel J., Semjonow A., Schrader A., Krabbe L. (2016)

In: PloS one, 11(9).

Forschungsartikel (Zeitschrift)

The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells

Steinestel K., Eder S., Ehinger K., Schneider J., Genze F., Winkler E., Wardelmann E., Schrader A., Steinestel J. (2016)

In: Tumor Biology, 37(5).

Forschungsartikel (Zeitschrift)

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer

Mikah P, Krabbe LM, Eminaga O, Herrmann E, Papavassilis P, Hinkelammert R, Semjonow A, Schrader AJ, Boegemann M (2016)

In: BMC Cancer, 16.

Forschungsartikel (Zeitschrift)

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer

Schlack K, Krabbe LM, Fobker M, Schrader AJ, Semjonow A, Boegemann M (2016)

In: ((Bitte Journal prüfen)), 17.

Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017) In: ((Bitte Journal prüfen)), 71. Forschungsartikel (Zeitschrift)
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017) In: ((Bitte Journal prüfen)), 18. Forschungsartikel (Zeitschrift)
Influence of statins on survival outcome in patients with metastatic castration resistant prostate cancer treated with abiraterone acetate Boegemann M., Schlack K., Fischer A., Gerß J., Steinestel J., Semjonow A., Schrader A., Krabbe L. (2016) In: PloS one, 11(9). Forschungsartikel (Zeitschrift)
The safety and efficacy of gemcitabine for the treatment of bladder cancer Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 16(3). Forschungsartikel (Zeitschrift)
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells Steinestel K., Eder S., Ehinger K., Schneider J., Genze F., Winkler E., Wardelmann E., Schrader A., Steinestel J. (2016) In: Tumor Biology, 37(5). Forschungsartikel (Zeitschrift)
Erratum to: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells (Tumor Biol., DOI 10.1007/s13277-015-4509-5) Steinestel K., Eder S., Ehinger K., Schneider J., Genze F., Winkler E., Wardelmann E., Schrader A., Steinestel J. (2016) In: Tumor Biology, 37(2). Forschungsartikel (Zeitschrift)
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer Mikah P, Krabbe LM, Eminaga O, Herrmann E, Papavassilis P, Hinkelammert R, Semjonow A, Schrader AJ, Boegemann M (2016) In: BMC Cancer, 16. Forschungsartikel (Zeitschrift)
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate Boegemann M, Schlack K, Fischer AK, Gerß J, Steinestel J, Semjonow A, Schrader AJ, Krabbe LM (2016) In: PloS one, 11. Forschungsartikel (Zeitschrift)
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer Schlack K, Krabbe LM, Fobker M, Schrader AJ, Semjonow A, Boegemann M (2016) In: ((Bitte Journal prüfen)), 17. Forschungsartikel (Zeitschrift)
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 5. Forschungsartikel (Zeitschrift)